文献速递白血病造血干细胞移植与细胞治疗

双阴性T细胞通过TNFα-JAK1-ICAM-1细胞毒性轴杀伤急性髓系白血病

Double-negative T cells utilize a TNFα-JAK1-ICAM-1 cytotoxic axis against acute myeloid leukemia.
PubMed 文献 · Blood Adv · 2024-01-01

该研究采用基于流式细胞术的高通量筛选,比较双阴性T细胞(DNT)与敏感或耐药急性髓系白血病(AML)细胞相互作用时的表面分子表达谱,鉴定出TNFα依赖的细胞毒性通路。DNT分泌的TNFα经非经典JAK1依赖途径上调AML细胞ICAM-1,通过ICAM-1与淋巴细胞功能相关抗原1结合增强杀伤,包括对DNT耐药的白血病细胞。

要点

  • DNT与敏感AML细胞作用时分泌TNFα,使AML细胞对DNT杀伤敏感,包括原本耐药的细胞。
  • TNFα通过非经典JAK1依赖途径上调AML细胞ICAM-1。
  • DNT经ICAM-1与淋巴细胞功能相关抗原1更有效结合AML细胞,增强杀伤。

核心结论

  • 研究揭示DNT杀伤AML的TNFα-JAK1-ICAM-1轴,以提高治疗疗效。

研究设计与样本

  • 采用基于流式细胞术的高通量筛选,比较DNT与DNT敏感或耐药AML细胞相互作用时的表面分子表达谱。

主要发现

  • DNT与敏感AML靶细胞相遇时分泌的TNFα使AML细胞对DNT介导的杀伤敏感,包括原本对DNT耐药的细胞。
  • TNFα通过非经典JAK1依赖途径上调AML细胞ICAM-1。
  • DNT通过ICAM-1与淋巴细胞功能相关抗原1更有效地与AML细胞结合,导致杀伤增强。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Allogeneic double-negative T cells (DNTs) are a rare T-cell subset that effectively target acute myeloid leukemia (AML) without inducing graft-versus-host disease in an allogeneic setting. A phase 1 clinical trial demonstrated the feasibility, safety, and potential efficacy of allogeneic DNT therapy among patients with relapsed AML. However, the molecular mechanisms of DNT-mediated cytotoxicity against AML remain elusive. Thus, we used a flow cytometry-based high throughput screening to compare the surface molecule expression profile on DNTs during their interaction with DNT-susceptible or -resistant AML cells and identified a tumor necrosis factor α (TNFα)-dependent cytotoxic pathway in DNT-AML interaction. TNFα secreted by DNTs, upon encountering susceptible AML targets, sensitized AML cells to DNT-mediated killing, including those otherwise resistant to DNTs. Mechanistically, TNFα upregulated ICAM-1 on AML cells through a noncanonical JAK1-dependent pathway. DNTs then engaged with AML cells more effectively through an ICAM-1 receptor, lymphocyte function-associated antigen 1, leading to enhanced killing. These results reveal a TNFα-JAK1-ICAM-1 axis in DNT-mediated cytotoxicity against AML to improve therapeutic efficacy.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Tin E, Lee JB, Khatri I, et al. Double-negative T cells utilize a TNFα-JAK1-ICAM-1 cytotoxic axis against acute myeloid leukemia. Blood Adv. 2024. PMID: 38547431. doi:10.1182/bloodadvances.2023011739

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。